…
The Medicines (Products for Human Use) (Fees) Regulations 2016, 4
Fee for scientific advice: application for, or variation to, EU marketing authorisation
The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020188Law
… advice given to small and medium companies (10A) (1) The fee payable in connection with a meeting mentioned in any of regulations 4 to 10 is waived where the person by whom the fee would otherwise be payable is established in the United …
The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 20233Law
In regulation 4 (fee for scientific advice: application for, or variation to, EU marketing authorisation)— (a) in paragraph (a), for “£2,201” substitute “£2,421”, (b) in paragraph (b), for “£2,763” substitute …
The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 202512Law
In regulation 11 (time for payment of fees under regulations 4 to 10), for “4 to 10”, in each place it occurs (including the heading to the regulation), substitute “3A to 8”.
Changed on 1 Apr 2025
Unless regulation 5 applies, the fee payable by a person with whom the licensing authority holds a meeting in order to provide scientific advice with a view to that person making an application for an EU marketing authorisation or an application for the variation of an EU marketing authorisation, is—
(a) £2,421, if the advice provided at that meeting consists of advice in connection with—
(i) quality development only; or
(ii) safety development only;
(b) £3,039, if the advice provided at that meeting consists only of advice in connection with clinical development;
(c) £3,367, if the advice provided at that meeting consists only of advice in connection with quality and safety development;
(d) £3,986, if the advice provided at that meeting consists of advice in connection with—
(i) quality and clinical development; or
(ii) safety and clinical development;
(e) £4,936, if the advice provided at that meeting consists of advice in connection with quality, safety and clinical development.…
- 1 Apr 2025 – todayin force
- 1 Apr 2023 – 1 Apr 2025earlier wording
- 11 Feb 2016 – 1 Apr 2023earlier wording